HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

7th Edition of Cardiology World Conference

October 08-10, 2026 | Tokyo, Japan

October 08 -10, 2026 | Tokyo, Japan

Atrial Fibrillation

Atrial Fibrillation

Atrial Fibrillation (AF) stands as a common cardiac rhythm disorder marked by irregular and frequently accelerated heartbeats. This condition arises when the heart's upper chambers (atria) undergo a quivering or fluttering motion, disrupting the normal electrical impulses that coordinate heartbeats. Consequently, the heart may struggle to efficiently pump blood, potentially leading to complications like blood clots, strokes, or heart failure. Although AF can affect individuals of various age groups, its prevalence tends to increase with age, with factors such as hypertension, diabetes, and heart disease heightening the risk. Recognizable symptoms encompass palpitations, fatigue, dizziness, and shortness of breath. The timely identification and effective management of Atrial Fibrillation are pivotal in reducing associated risks and improving the quality of life for those impacted. Treatment approaches typically include medications, lifestyle adjustments, and, in specific cases, medical procedures designed to restore or regulate the heart's rhythm. Ongoing research efforts contribute to a growing understanding of AF mechanisms, offering promise for innovative treatment options and advancements in patient care.

Submit your abstract Today

Watsapp